ArticleBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2016

Comparison of Subcutaneous versus Intravenous Alemtuzumab for Graft-versus-Host Disease Prophylaxis with Fludarabine/Melphalan-Based Conditioning in Matched Unrelated Donor Allogeneic Stem Cell Transplantation.

Khilna Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.